1. Project
  2. TRIBBLES
  3. Organisations

Characterizing the clinical relevance and the mechanism underlying TRIB2-mediated drug resistance to MEK inhibitiors in the context of melanoma

Full project page

Organisations map overview


Powered by Chris Decubber BV